Notable Labs

Personalized combination therapies for cancer patients.

News and Press

Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer

MedCity News • April 15, 2019

Researchers at Stanford took blood samples from patients and sent them to Chicago-based Tempus for genomic sequencing of the person’s cancer. Another sample was sent to Notable, which used its AI-based automated laboratory system to test hundreds of potential drug treatments against the disease and provided treatment recommendations based on that analysis. Stanford clinicians then used this data (alongside the clinical features of the patient) to create a report with individualized recommendations that could inform future treatment.

Peninsula biotech's nonprofit deal spotlights unique attack on cancer in kids

San Francisco Business Times • Jan. 22, 2019

The partnership between for-profit Notable Labs and nonprofit Cures Within Reach could bring a childhood cancer treatment — a combination discovered by Foster City's Notable Labs of a generic drug and a natural product — to market faster and cheaper.

Show all News and Press (4 more)

Blog Posts

Notable Labs is changing the landscape of how we view and treat hematological cancer, one sample at a time.

November 20, 2020

Notable Labs Announces Partnership With All4Cure

October 28, 2020

Emerging Technical and Precision Medicine Approaches for Higher Risk Myelodysplastic Syndromes

October 13, 2020

Notable Labs Announces Addition of Thomas Bock to Board of Directors

October 12, 2020
Show all Blog Posts (22 more)